These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23983854)

  • 21. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
    de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
    Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus-A case report and review of the literature.
    Babi MA; Robinson CP; Maciel CB
    SAGE Open Med Case Rep; 2017; 5():2050313X17745206. PubMed ID: 29238581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey study to characterize use of Spice products (synthetic cannabinoids).
    Vandrey R; Dunn KE; Fry JA; Girling ER
    Drug Alcohol Depend; 2012 Jan; 120(1-3):238-41. PubMed ID: 21835562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spice/K2 drugs--more than innocent substitutes for marijuana.
    Zawilska JB; Wojcieszak J
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.
    Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
    Am J Addict; 2012; 21(4):320-6. PubMed ID: 22691010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.
    Thomas BF; Lefever TW; Cortes RA; Grabenauer M; Kovach AL; Cox AO; Patel PR; Pollard GT; Marusich JA; Kevin RC; Gamage TF; Wiley JL
    J Pharmacol Exp Ther; 2017 Apr; 361(1):162-171. PubMed ID: 28087785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and financial implications of emergency department visits for synthetic marijuana.
    Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
    Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic cannabinoids: the hidden side of Spice drugs.
    Pintori N; Loi B; Mereu M
    Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [First generalized tonic-clonic seizure].
    Realfsen MS; Bø SM; Lossius MI; Nakken KO
    Tidsskr Nor Laegeforen; 2015 Aug; 135(14):1256-8. PubMed ID: 26269067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ["Spice"--synthetic cannabinoids with dangerous effects].
    Personne M; Westerbergh J; Hammer-Pettersen L
    Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.
    Schindler CW; Gramling BR; Justinova Z; Thorndike EB; Baumann MH
    Drug Alcohol Depend; 2017 Oct; 179():387-394. PubMed ID: 28846955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB
    Funada M; Takebayashi-Ohsawa M
    Toxicol Appl Pharmacol; 2018 Jan; 338():1-8. PubMed ID: 29042214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported Use of K2/Spice for Appetite Stimulation: A Case Report.
    Torres C; Espiridion ED
    Cureus; 2020 Apr; 12(4):e7860. PubMed ID: 32483510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.
    Hermanns-Clausen M; Kithinji J; Spehl M; Angerer V; Franz F; Eyer F; Auwärter V
    Drug Test Anal; 2016 Oct; 8(10):1030-1038. PubMed ID: 26768345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
    Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
    Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.